The global stents market is expected to reach $13,522.8 million by 2027, growing at a mid single digit CAGR from 2020 to 2027. The market is segmented by product, material, application, end-users and geography.
Stents are the miniaturized, flexible or expandable tube like structures used to widen and establish patency of the clogged vascular or non-vascular tubular structures and to ensure steady flow of body fluids through them.
Compared to the traditional highly invasive surgical repair procedures, the current minimally invasive transcatheter therapeutic procedures with highly efficient, technologically advanced stent products assure patients and healthcare providers with improved efficiency, effectiveness and quicker restoration of the narrowed vessel's or duct's natural function.
Increased utilization of the various stent products for the numerous and varied types of vascular and non-vascular obstructive conditions and cerebral aneurysm among the patients, elevating inclination of the value centric global patient pool towards the minimally invasive, technologically advanced stent products with better therapeutic outcomes and the need to rapidly mitigate the clinical manifestations associated with blocked vascular and non-vascular hollow organs or weakened vascular bed, reduce hospitalization duration and ease and improve the patient's condition quickly through efficient and safer interventional products are fuelling the stents global market.
The stents global market is consolidated with few companies dominating and occupying major share of the market. Some of the leading players in stents market are Boston Scientific Corporation (U.S.), Abbott Laboratories (U.S.), Medtronic PLC (Ireland), Terumo Corporation (Japan), Cook Medical LLC (U.S.), Cardinal Health Inc. (U.S.), Becton, Dickinson and company (U.S.), B. Braun Melsungen AG (Germany), Biotronik SE & Co. KG (Germany), Blue Sail Medical Co. Ltd. (Biosensors International Pte. Ltd.) (China) and others.
Key Topics Covered:
1 Executive Summary
3 Market Analysis 3.1 Introduction 3.2 Market Segmentation 3.3 Factors Influencing Market 3.3.1 Drivers and Opportunities 126.96.36.199 Escalating Prevalence of Vascular and Non-Vascular Stenotic Diseases and Cerebral Aneurysm 188.8.131.52 Elevating Inclination Towards Minimally Invasive Therapeutic Approaches 184.108.40.206 The Trend of Coronary Stent Price Slashing and Increasing Competitiveness of Domestic Players in APAC Countries 220.127.116.11 Emergence of Technologically Advanced Products 18.104.22.168 Escalating Geriatric Population and Feasibility of Drug Eluting Stents in Them 22.214.171.124 Acquisitions and Distribution Agreements to Open an Array of Opportunities for the Market to Flourish 126.96.36.199 Favourable Reimbursement Policies Escalating Stent Technology Diffusion in Developed Nations 3.3.2 Restraints and Threats 188.8.131.52 Stringent Regulatory Bodies Guiding Stent Manufacturers 184.108.40.206 The Threat of Commercialized Stent Recalls 220.127.116.11 Lack of Skilled, Experienced and Trained Healthcare Professionals 18.104.22.168 Adverse Effects of Stents 22.214.171.124 Concerns Over Irrational Stenting and Under-Performance of Stents in Complex Stenotic Diseases or Lesions 3.4 Regulatory Affairs 3.4.1 International Organization for Standardization 126.96.36.199 ISO 9001: 2015 Quality Management System 188.8.131.52 ISO 14644-1 Clean Room Standards 184.108.40.206 ISO 13485 Medical Devices 220.127.116.11 ISO 10993 Biological Evaluation of Medical Devices 18.104.22.168 ISO 14971: Risk Management of Medical Devices 22.214.171.124 ISO 25539-2: 2020 Cardiovascular Implants - Endovascular Devices - Part 2: Vascular Stents 126.96.36.199 ISO 25539-1 188.8.131.52 ISO 12417-1 184.108.40.206 ISO/TS 17137 220.127.116.11 ISO 17327-1 18.104.22.168 IEC 60601-1 Medical Electrical Equipment Standard 3.4.2 ASTM International Standards 3.4.3 U.S. 3.4.4 Canada 3.4.5 Europe 3.4.6 Japan 3.4.7 China 3.4.8 India 3.5 Technological Advancements 3.5.1 Introduction 3.5.2 Smart Stents 3.5.3 3D-Printed Stents 3.5.4 Indirect 4D Printing and Microstents 3.5.5 Nanocoated Non-Drug Eluting Stent and Ultrashort DAPT 3.5.6 Bioengineered Stents 3.5.7 Gene Eluting Stents (GES) 3.5.8 Bioresorbable Stents 3.6 Stents Coating Materials 3.6.1 Inorganic Coating Materials 3.6.2 Organic Coating Materials 3.6.3 Biological Coating Materials or Biocoatings 3.6.4 Chemotheraputics or Drugs 3.7 Porter's Five Force Analysis 3.8 Supply Chain Analysis 3.9 Reimbursement Scenario 3.10 Patent Trends 3.11 Regulatory Approval Analysis 3.12 Clinical Trials 3.13 Market Share Analysis by Major Players 3.13.1 Stents Global Market Share Analysis 3.13.2 Coronary Stents Global Market Share Analysis 3.13.3 Peripheral Stents Global Market Share Analysis 3.13.4 Neurovascular Stents Global Market Share Analysis 22.214.171.124 Flow Diverters Global Market Share Analysis 126.96.36.199 Intracranial Stent Global Market Share Analysis 188.8.131.52 Carotid Stent Global Market Share Analysis 3.13.5 Gastrointestinal Stents Global Market Share Analysis 3.13.6 Drug Eluting Stents Global Market Share Analysis 3.14 Stents - Number of Procedures by Region 3.15 Stents Company Comparison Table by Revenue, Product, Product Type, Application, Material and Indication
4 Stents Global Market, by Product 4.1 Introduction 4.2 Bare Metal Stents 4.3 Drug Eluting Stents 4.4 Bioresorbable Stents 4.5 Other Stents
5 Stents Global Market, by Material 5.1 Introduction 5.2 Metal Alloy Based Stents 5.3 Polymer Based Stents
6 Stents Global Market, by Application 6.1 Introduction 6.2 Vascular Stents 6.3 Non-Vascular Stents
7 Stents Global Market, by End-users 7.1 Introduction 7.2 Hospitals 7.3 Ambulatory Surgery Centers 7.4 Other End-users